Clinical trial
Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment
NCT06915870 is registered in ClinicalTrials.gov with Fatima Maqsood as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment
- Lead sponsor
- Fatima Maqsood
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 12, 2024
- Completion date
- January 13, 2025
- Enrollment
- 108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.